Sutro Biopharma Tangible Net Worth Ratio
Sutro Biopharma tangible net worth ratio. Sutro Biopharma (STRO) has a Tangible Net Worth Ratio of 100.0% as of December 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($44.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check STRO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Sutro Biopharma (2018–2024)
Tangible net worth ratio of Sutro Biopharma from 2018 to 2024. This chart shows how Sutro Biopharma's Tangible Net Worth Ratio has changed across 7 annual periods from 2018 to 2024. As of December 2024, the ratio stands at 100.0%, reflecting net assets of $44.60 Million with intangible assets of $0.00 USD. See STRO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Sutro Biopharma Tangible Net Worth Ratio by Year (2018–2024)
Sutro Biopharma tangible net worth ratio by year from 2018 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Sutro Biopharma from 2018 to 2024, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is Sutro Biopharma worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $44.60 Million | $0.00 | $387.21 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $149.65 Million | $0.00 | $470.74 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $217.05 Million | $0.00 | $406.94 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $252.56 Million | $0.00 | $341.41 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $332.05 Million | $0.00 | $394.11 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $97.79 Million | $0.00 | $156.37 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $131.54 Million | $0.00 | $223.14 Million | — |